Nakai K, Umehara M, Minamida A, Yamauchi-Sawada H, Sunahara Y, Matoba Y
Sci Rep. 2023; 13(1):8705.
PMID: 37248327
PMC: 10227064.
DOI: 10.1038/s41598-023-35850-w.
Estil Les E, Tellez N, Nacher M, Montanya E
Cell Transplant. 2018; 27(11):1684-1691.
PMID: 30269527
PMC: 6299193.
DOI: 10.1177/0963689718801006.
Grigorian A, OBrien C
J Clin Transl Hepatol. 2015; 2(2):95-102.
PMID: 26357620
PMC: 4521265.
DOI: 10.14218/JCTH.2014.00011.
Frost P, Chen S, Mezzles M, Voruganti V, Nava-Gonzalez E, Arriaga-Cazares H
J Med Primatol. 2015; 44(4):202-17.
PMID: 26122701
PMC: 5897100.
DOI: 10.1111/jmp.12182.
Moraes I, Manzan-Martins C, Moura de Gouveia N, Calabria L, Hiraki K, da Silva Moraes A
Evid Based Complement Alternat Med. 2015; 2015:316017.
PMID: 25763088
PMC: 4339860.
DOI: 10.1155/2015/316017.
Advancements and challenges in generating accurate animal models of gestational diabetes mellitus.
Pasek R, Gannon M
Am J Physiol Endocrinol Metab. 2013; 305(11):E1327-38.
PMID: 24085033
PMC: 4073988.
DOI: 10.1152/ajpendo.00425.2013.
Anti hyperglycemic activities of Annona muricata (Linn).
Adeyemi D, Komolafe O, Adewole O, Obuotor E, Adenowo T
Afr J Tradit Complement Altern Med. 2010; 6(1):62-9.
PMID: 20162043
PMC: 2816521.
Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors.
Reidy D, Tang L, Saltz L
Nat Clin Pract Oncol. 2009; 6(3):143-52.
PMID: 19190591
DOI: 10.1038/ncponc1326.
Endocrine sequelae of cancer and cancer treatments.
Stava C, Jimenez C, Vassilopoulou-Sellin R
J Cancer Surviv. 2008; 1(4):261-74.
PMID: 18648961
DOI: 10.1007/s11764-007-0038-6.
The mechanisms of alloxan- and streptozotocin-induced diabetes.
Lenzen S
Diabetologia. 2007; 51(2):216-26.
PMID: 18087688
DOI: 10.1007/s00125-007-0886-7.
Chromatin as a target for the DNA-binding anticancer drugs.
Majumder P, Pradhan S, Devi P, Pal S, Dasgupta D
Subcell Biochem. 2007; 41:145-89.
PMID: 17484128
PMC: 7121056.
DOI: 10.1007/1-4020-5466-1_8.
DNA and the chromosome - varied targets for chemotherapy.
Nelson S, Ferguson L, Denny W
Cell Chromosome. 2004; 3(1):2.
PMID: 15157277
PMC: 421739.
DOI: 10.1186/1475-9268-3-2.
Cancer, chemotherapy and anaesthesia.
Chung F
Can Anaesth Soc J. 1982; 29(4):364-71.
PMID: 7049331
DOI: 10.1007/BF03007527.
Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.
Fisher R, Mandell G, Bostick F, McMenamin M, Anderson T
Clin Exp Immunol. 1980; 39(2):416-25.
PMID: 6446427
PMC: 1538078.
Intestinal and liver toxicity of antineoplastic drugs.
McDonald G, Tirumali N
West J Med. 1984; 140(2):250-9.
PMID: 6375139
PMC: 1021607.
Multiple endocrine neoplasia syndromes.
Pont A
West J Med. 1980; 132(4):301-12.
PMID: 6247851
PMC: 1272066.
Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.
Melia W, Nunnerley H, Johnson P, Williams R
Br J Cancer. 1982; 46(3):331-9.
PMID: 6181801
PMC: 2011132.
DOI: 10.1038/bjc.1982.208.
N-methyl antitumour agents. A distinct class of anticancer drugs?.
Newell D, Gescher A, Harland S, Ross D, Rutty C
Cancer Chemother Pharmacol. 1987; 19(2):91-102.
PMID: 3552281
DOI: 10.1007/BF00254559.
Morphological change in pancreatic islets, insulin binding and intracellular glucose metabolism in adipocytes of streptozotocin-induced diabetic rats.
Cha B, Son H, Min B, Kim H
Korean J Intern Med. 1987; 2(1):8-17.
PMID: 3154820
PMC: 4534923.
DOI: 10.3904/kjim.1987.2.1.8.
CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts.
Fiebig H, Widmer K, Winterhalter B, LOHR G
Cancer Chemother Pharmacol. 1989; 23(6):337-40.
PMID: 2713955
DOI: 10.1007/BF00435832.
